Cargando…

The Usefulness of Anti-HCV Signal to Cut-off Ratio in Predicting Viremia in Anti-HCV in Patients With Hepatitis C Virus Infection

BACKGROUND: Hepatitis C Virus (HCV) infection is diagnosed by antibody and RNA based methods. Patients with anti-HCV sample rate/cutoff rate (S/CO) ratios > 1 are reported as anti-HCV positive. RNA based methods are introduced to confirm positivity in seropositive samples. OBJECTIVES: The current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjbar Kermani, Fahimeh, Sharifi, Zohreh, Ferdowsian, Fereshteh, Paz, Zahrah, Tavassoli, Farzaneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449862/ https://www.ncbi.nlm.nih.gov/pubmed/26034549 http://dx.doi.org/10.5812/jjm.8(4)2015.17841

Ejemplares similares

Anti-HCV Signal-to-Cutoff Ratio in Predicting Hepatitis C Viremia
por: Kim, Hyon-Suk
Publicado: (2009)

Significance of Anti-HCV Signal-to-Cutoff Ratio in Predicting Hepatitis C Viremia
por: Seo, Yeon Seok, et al.
Publicado: (2009)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
por: Liu, Hung-Yin, et al.
Publicado: (2021)

Association of HCV genotype with viral load among Iranian blood donors: a penalized logistic regression
por: Ranjbar Kermani, Fahimeh, et al.
Publicado: (2019)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships
por: Hahn, Judith A, et al.
Publicado: (2019)

Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study
por: Desai, Seema N., et al.
Publicado: (2016)

Direct anti-HCV agents
por: Zhang, Xingquan
Publicado: (2016)

The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury—The Women’s Interagency HIV Study
por: Keating, Sheila M., et al.
Publicado: (2017)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

New anti-HCV agents in the pipeline
por: Zoulim, Fabien
Publicado: (2014)

Interferon Alpha Therapy in Patients with Chronic Type C Hepatitis: Changes of Serum ALT, Anti-HCV & HCV-RNA
por: Cho, Ho Jun, et al.
Publicado: (1992)

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
por: Meyer, Manuela F, et al.
Publicado: (2007)

Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2022)

Anti-HCV prevalence in the general population of Lithuania
por: Liakina, Valentina, et al.
Publicado: (2012)

Recent advances in the anti-HCV mechanisms of interferon
por: Huang, Menghao, et al.
Publicado: (2014)

The study of hepatitis B surface antigen and anti-HCV in HIV infected patients
por: Girish, N, et al.
Publicado: (2012)

Evaluation of the VIDAS Anti-HCV Assay for Detection of Hepatitis C Virus Infection
por: Hyun, Jungwon, et al.
Publicado: (2016)

Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
por: Nguyen, Truong Tam, et al.
Publicado: (2018)

Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study
por: Lin, Shih-Yi, et al.
Publicado: (2017)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients
por: Sadri, Mahrou, et al.
Publicado: (2015)

Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

Biosynthesis of anti-HCV compounds using thermophilic microorganisms
por: Rivero, Cintia W., et al.
Publicado: (2012)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions
por: Sobrino-Vegas, Paz, et al.
Publicado: (2014)

Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies
por: Su, Yi-Tse, et al.
Publicado: (2022)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail
por: Neesgaard, Bastian, et al.
Publicado: (2018)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion
por: Hu, Longbo, et al.
Publicado: (2014)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

Enhanced anti-HCV activity of interferon alpha 17 subtype
por: Dubois, Aurelie, et al.
Publicado: (2009)

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
por: Elfiky, Abdo A.
Publicado: (2020)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia
por: Russi, Sabino, et al.
Publicado: (2014)

Analysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patients
por: Pereira, Karen, et al.
Publicado: (2014)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_04fcn3t8cuvsucg3a6fl7uft33